Early studies in obese individuals showed some reductions in body fat mass, but findings are not consistent across trials: In one clinical trial, AOD9604 did not demonstrate statistically significant weight loss compared to placebo, suggesting its fat-burning effects may be modest without lifestyle intervention (summary of trials)
you dont want to have this occur in your system
Because it does not suppress appetite, it can theoretically be combined with GLP-1 agonists to add a lipolytic component to the appetite suppression mechanism, though clinical data on this combination is lacking
They describe what is being studied , not proven benefits, approved uses, or promised results
In summary, theres no shortcut
The statements on this page have not been evaluated by the Food and Drug Administration